Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News QHSLab Inc USAQ

Financial Services Technology Scientific & Technical Instruments
QHSLab, Inc. is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians (PCPs). It is focused on enabling PCPs to improve their business by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. It is providing PCPs with the... see more

Recent & Breaking News (OTCQB:USAQ)

QHSLab, Inc. Launches a "Long COVID" Digital Health Tool for Primary Care Physicians

GlobeNewswire September 20, 2022

QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services

GlobeNewswire June 24, 2022

QHSLab, Inc's CEO Addresses Current Market Conditions & Recent Quarterly Performance

GlobeNewswire May 24, 2022

New $90 million annual addressable market for QHSLab's latest product, the Allergy Quick Test, branded AllergiQT(TM).

GlobeNewswire May 10, 2022

QHSLab. Issues Update and Investor Presentation May 2022

GlobeNewswire May 9, 2022

USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.

GlobeNewswire April 19, 2022

USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire April 5, 2022

QHSLab Expands Digital Prescription Product Portfolio in 2022

GlobeNewswire February 16, 2022

USA Equities Corp's QHSLab Digital Health Platform Strategy is Backed by Latest Research Published in the Journal of the American Medical Association (JAMA)

GlobeNewswire January 7, 2022

USA Equities Corp. Introduces AllergiQT(TM) - Quick Test, Further Expanding Market Presence

GlobeNewswire November 29, 2021

USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note

GlobeNewswire November 16, 2021

USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand

GlobeNewswire October 19, 2021

USA Equities Corp. Issues Updated September 2021 Investor Presentation

GlobeNewswire September 22, 2021

USAQ CEO Discusses Financial Improvements in Q2, Product Projections in Audio Interview with SmallCapVoice.com

Accesswire September 9, 2021

USA Equities Corp. Announces Strong Second Quarter 2021 Results

GlobeNewswire August 17, 2021

Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network

GlobeNewswire August 5, 2021

USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results

GlobeNewswire July 15, 2021

USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services

GlobeNewswire June 29, 2021

USA Equities Corp. Acquires AllergiEnd®Assets

GlobeNewswire June 24, 2021

USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop

GlobeNewswire June 9, 2021